<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gallo MF</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>Futura Medical Developments</funding><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><pagination>1133-1139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9300773</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>59(9)</volume><pubmed_abstract>We tested whether CSD500 (Futura Medical; Guildford, UK), a novel condom containing erectogenic gel designed to increase penile firmness, penile size, and erection duration, results in greater sexual pleasure. In 2017-2020, we randomized heterosexual couples in Thanh Hoa, Vietnam to use CSD500 (N = 248) or standard condoms (N = 252) and followed them up for six months. Women completed the Quality of Sexual Experience (QSE) scale; men completed the QSE, Sexual Experience Questionnaire (SEX-Q), and 11 condom acceptability items. Female participants' mean age was 32.1 years (&lt;i>SD&lt;/i> = 0.24; range 21-46). QSE scores were higher among women (&lt;i>B&lt;/i>, 0.12; 95% CI, 0.03-0.21) and men (&lt;i>B&lt;/i>, 0.21; 95% CI, 0.08-0.35) in the CSD500 relative to the control arm. SEX-Q scores were higher among men in the CSD500 compared to the control arm (&lt;i>B&lt;/i>, 3.22; 95% CI, 1.53-4.91). Higher proportions of men in the CSD500 relative to the control arm reported the condom felt "natural" during sex (68.6% vs. 32.3%; &lt;i>p&lt;/i> &lt; .01) and that sex with the condom felt "a lot better" than condomless sex (15.5% vs. 5.3%; &lt;i>p&lt;/i> &lt; .01). Compared with standard condoms, CSD500 use was associated with higher reports of sexual pleasure and condom acceptability.</pubmed_abstract><journal>Journal of sex research</journal><pubmed_title>Effects of a Novel Erectogenic Condom on Men and Women's Sexual Pleasure: Randomized Controlled Trial.</pubmed_title><pmcid>PMC9300773</pmcid><funding_grant_id>R01 HD084637</funding_grant_id><funding_grant_id>n/a</funding_grant_id><funding_grant_id>UL1TR001070</funding_grant_id><funding_grant_id>UL1 TR001070</funding_grant_id><funding_grant_id>R01HD084637</funding_grant_id><pubmed_authors>Andridge R</pubmed_authors><pubmed_authors>Luong TN</pubmed_authors><pubmed_authors>Casterline J</pubmed_authors><pubmed_authors>Gallo MF</pubmed_authors><pubmed_authors>Nguyen NC</pubmed_authors><pubmed_authors>Le VT</pubmed_authors><pubmed_authors>Luff A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of a Novel Erectogenic Condom on Men and Women's Sexual Pleasure: Randomized Controlled Trial.</name><description>We tested whether CSD500 (Futura Medical; Guildford, UK), a novel condom containing erectogenic gel designed to increase penile firmness, penile size, and erection duration, results in greater sexual pleasure. In 2017-2020, we randomized heterosexual couples in Thanh Hoa, Vietnam to use CSD500 (N = 248) or standard condoms (N = 252) and followed them up for six months. Women completed the Quality of Sexual Experience (QSE) scale; men completed the QSE, Sexual Experience Questionnaire (SEX-Q), and 11 condom acceptability items. Female participants' mean age was 32.1 years (&lt;i>SD&lt;/i> = 0.24; range 21-46). QSE scores were higher among women (&lt;i>B&lt;/i>, 0.12; 95% CI, 0.03-0.21) and men (&lt;i>B&lt;/i>, 0.21; 95% CI, 0.08-0.35) in the CSD500 relative to the control arm. SEX-Q scores were higher among men in the CSD500 compared to the control arm (&lt;i>B&lt;/i>, 3.22; 95% CI, 1.53-4.91). Higher proportions of men in the CSD500 relative to the control arm reported the condom felt "natural" during sex (68.6% vs. 32.3%; &lt;i>p&lt;/i> &lt; .01) and that sex with the condom felt "a lot better" than condomless sex (15.5% vs. 5.3%; &lt;i>p&lt;/i> &lt; .01). Compared with standard condoms, CSD500 use was associated with higher reports of sexual pleasure and condom acceptability.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov-Dec</publication><modification>2024-11-14T13:29:31.128Z</modification><creation>2024-11-14T13:29:31.128Z</creation></dates><accession>S-EPMC9300773</accession><cross_references><pubmed>35060403</pubmed><doi>10.1080/00224499.2021.2024790</doi></cross_references></HashMap>